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Background: Genome-wide association studies (GWAS) identify regions of the genome that are associated with
particular traits, but do not typically identify specific causative genetic elements. For example, while a large number
of single nucleotide polymorphisms associated with type 2 diabetes (T2D) and related traits have been identified by
human GWAS, only a few genes have functional evidence to support or to rule out a role in cellular metabolism or
dietary interactions. Here, we use a recently developed Drosophila model in which high-sucrose feeding induces
phenotypes similar to T2D to assess orthologs of human GWAS-identified candidate genes for risk of T2D and
related traits.
Results: Disrupting orthologs of certain T2D candidate genes (HHEX, THADA, PPARG, KCNJ11) led to sucrose-dependent
toxicity. Tissue-specific knockdown of the HHEX ortholog dHHEX (CG7056) directed metabolic defects and
enhanced lethality; for example, fat-body-specific loss of dHHEX led to increased hemolymph glucose and
reduced insulin sensitivity.
Conclusion: Candidate genes identified in human genetic studies of metabolic traits can be prioritized and
functionally characterized using a simple Drosophila approach. To our knowledge, this is the first large-scale effort to
study the functional interaction between GWAS-identified candidate genes and an environmental risk factor such as
diet in a model organism system.
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The search for genetic risk factors for common human
diseases often relies on the use of linkage and association
studies to establish correlation between genomic markers
and disease risk. These studies require additional func-
tional evaluation of candidate genes, including their pos-
sible interaction with diet and environment. The number
of candidate genes is typically large and the development* Correspondence: baranski@wustl.edu
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reproduction in any medium, provided the orof appropriate genetic tools in mammalian systems is
slow. By contrast, large-scale genetic screens, using
widely available genetic tools, are routinely conducted
in the fruit fly Drosophila melanogaster. In this study,
we used Drosophila to screen candidate genes identified
in human genome-wide scans as associated with risk of
metabolic abnormalities such as type 2 diabetes. We
show that a number of human candidate genes have fly
orthologs that play an important role in Drosophila tol-
erance to high dietary sucrose. We further explored
some of the specific metabolic abnormalities that can
result when these genes’ activities are reduced in flies,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ortholog of human HHEX.
Background
Type 2 diabetes (T2D), a disease state characterized by
impaired insulin sensitivity and hyperglycemia, is one of
the world’s leading causes of mortality and morbidity
[1-3]. In recent years, genome-wide association studies
(GWAS) have had success in identifying susceptibility loci
for type 2 diabetes and related traits in humans [4,5].
These studies establish associations between markers,
such as single nucleotide polymorphisms (SNPs), and dis-
ease. However, they typically lack the resolution needed to
identify causal variants, because SNPs may exist in linkage
disequilibrium with multiple protein-coding loci as well as
with non-coding gene-regulatory elements that can act
over a long distance [6,7]. Mouse models of diabetes and
obesity can serve as convenient platforms to functionally
probe a small number of candidate genes [8], but this
approach is expensive and slow, limiting the number of
genes that can be readily assessed.
The biochemical pathways involved in growth and
metabolism are ancient and well conserved across the
animal kingdom from C. elegans and Drosophila to
rodents and humans [9]. Analogous to insulin and gluca-
gon in vertebrates, Drosophila insulin-like peptides (dILPs)
and adipokinetic hormone (Akh) regulate circulating
glucose homeostasis. In addition, many tissues known
to be important in type 2 diabetes have functional
analogs in Drosophila including blood, adipose tissue
and liver, skeletal muscle, pancreatic beta cells, brain,
and kidney [9]. Indeed, Drosophila melanogaster raised
on diets high in sugar exhibit hallmark features of type 2
diabetes including insulin resistance, fasting hypergly-
cemia, and increased fat storage [10].
Off-the-shelf genetic tools in Drosophila, including
mutations and inducible RNA interference (RNAi), allow
the functions of specific genes to be rapidly queried; a
Drosophila genetic approach has recently been used to
follow up a small-scale GWAS for Alzheimer pathology
[11]. Here we make use of the advantages of Drosophila as
a model system for exploration of whole-animal metabol-
ism. Starting from a subset of previously published human
SNPs and regions associated with disease risk, we utilize
Drosophila to screen candidate genes in each region in an
unbiased manner. We provide functional evidence that
disruption of some of these genes can predispose the flies
to dietary sucrose-induced lethality. We show in one
region that HHEX may contribute to type 2 diabetes
phenotypes including hyperglycemia and insulin insensi-
tivity; in addition, our data suggests two neighboring
genes may also contribute to the risk identified by GWAS.
Thus, in addition to implicating specific genes as disease
drivers, our work demonstrates the power of Drosophilato provide rapid, functional, diet- and environment-
sensitive assays for GWAS follow-up studies and to
deconvolute regions that contain multiple risk loci.
Results and discussion
Fly orthologs of human genes in disease risk-associated
regions
We focused on a set of 38 human genomic regions in
which SNPs have been associated with type 2 diabetes dis-
ease status [12-14] as well as related quantitative traits
(QTs), including levels of fasting blood glucose [15,16],
triglycerides [17-19], low-density lipoprotein (LDL)
[17,18], and high-density lipoprotein (HDL) [17,18]. We
included the latter SNPs since there is considerable over-
lap between mechanisms that regulate lipid and glucose
metabolism. Beginning with the 130 human genes located
within approximately 100 kb of each SNP, we identified fly
orthologs as inferred by Ensembl’s phylogenetic analyses
(release 43) [20,21] and found that 71 of the 130 candidate
human genes—within 33 of the 38 human genomic
regions—have fly orthologs with one-to-one, one-to-many,
many-to-one, or many-to-many orthology relationships. In
total, we identified 83 fly orthologs corresponding to 71
human genes under consideration. Human GWAS traits,
associated index SNPs, genomic regions, candidate genes,
and fly orthologs are listed in Table 1 and Additional file 1:
Table S1.
Screen for modifiers of sucrose tolerance
We and others have previously shown that flies fed high-
sugar diets, including a 1.0 M sucrose diet, exhibit
diabetes-like phenotypes [10,22]. Additionally, flies die as
larvae when fed very high levels of dietary sucrose (above
1.25 M), but survival to pupariation is comparable be-
tween flies fed 0.15 M and 1.0 M sucrose diets (Additional
file 1: Figure S1). We hypothesized that knocking down a
gene that mediates sucrose tolerance would affect larval
viability differently on high- vs. low-sucrose diets. Such a
gene would be required for survival to pupariation on a
1.0 M sucrose diet, but may prove dispensable on a
control 0.15 M sucrose diet.
To test this hypothesis and to identify modifiers of the
sucrose intolerance phenotype, we screened knockdowns
of the selected genes (Table 1) using the now-classic
GAL4/UAS system [23]. Fly lines containing inducible
RNA-interference (UAS-RNAi) elements were acquired
for most of these genes; multiple fly lines were available
for many loci, and a total of 137 RNAi fly lines were
tested. We used tubP-GAL4 to direct broad expression of
GAL4, which in turn induces broad expression of the
RNAi-encoding transgene. Sucrose tolerance was then
assessed by (i) scoring pupariation rates relative to non-
RNAi controls and (ii) comparing high-sucrose vs. low-
sucrose feeding. An important strength of this approach is
Table 1 Human genes identified by GWAS
Region Trait Genes
1p32.3 LDL TMEM61, BSND, PCSK9, USP24
1p31.3 TG ANGPTL3*, DOCK7, ATG4C**
1p13.3 LDL KIAA1324, SARS, CELSR2**, PSRC1, MYBPHL, SORT1
1p12 T2D ADAM30, NOTCH2
1q42.13 TG, HDL GALNT2
2p24.1 LDL APOB
2p23.3 T2D NRBP1**, KRTCAP3, IFT172, FNDC4, GCKR, C2orf16, ZNF512
2p21 T2D THADA**, PLEKHH2
2q24.3 FG NOSTRIN*, SPC25, G6PC2, ABCB11**
3p25.2 T2D PPARG**
3p14.1 T2D ADAMTS9*
3q27.3 T2D IGF2BP2*, C3orf65
5q13.3 LDL HMGCR, COL4A3BP
6p22.3 T2D CDKAL1
6p21.32 LDL HLA-DPA1, COL11A2, RXRB**, SLC39A7, HSD17B8, MIR219-1, RING1**, VPS52, RPS18
7p15.2 T2D JAZF1
7p13 FG AEBP1, MIR4649, POLD2, MYL7, GCK**, YKT6, CAMK2B
7q11.23 TG BAZ1B, BCL7B, TBL2, MLXIPL**, VPS37D, DNAJC30*, WBSCR22, STX1A
8p21.3 TG, HDL LPL**
8q24.11 T2D SLC30A8*
8q24.13 TG TRIB1*
9p21.3 T2D MTAP, CDKN2A, CDKN2B
9q31.1 HDL ABCA1
10p13 T2D NUDT5, CDC123, CAMK1D
10q23.33 T2D IDE*, KIF11*, HHEX**
10q25.2 T2D TCF7L2**
11p15.1 T2D NUCB2*, NCR3LG1, KCNJ11**, ABCC8*
11p11.2 T2D EXT2, ALX4
11q23.3 TG BUD13, ZNF259, APOA5, APOA4, APOC3, APOA1, SIK3
12q15 T2D TSPAN8, LGR5
12q23.3 HDL MYO1H, KCTD10*, UBE3B, MMAB, MVK**
15q21.3 HDL LIPC**
16q12.1 T2D RPGRIP1L, FTO
16q12.2 HDL CETP, NLRC5, SLC12A3**, HERPUD1, MIR138-2
18q21.1 HDL LIPG**, ACAA2
19p13.2 LDL SMARCA4, LDLR, SPC24, KANK2
19p13.11 TG, LDL GATAD2A, TSSK6, NDUFA13**, YJEFN3, CILP2, PBX4, LPAR2, GMIP, ATP13A1**
19q13.33 LDL BCL3, CBC, BCAM, PVRL2, TOMM40**, APOE, APOC1, APOC4, APOC2, CLPTM1, RELB**
List of all human genes located near the SNPs considered in the study. Asterisks indicate genes with Drosophila orthologs that function in sucrose tolerance in
Drosophila; doubled asterisks indicate strong hits. Italicized genes were not evaluated in the Drosophila sucrose-intolerance screen, mostly because they lack
Drosophila orthologs. References and more detailed experimental results are in Additional file 1: Table S1.
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http://www.biomedcentral.com/1471-2164/14/136that we can distinguish between sucrose-dependent and
sucrose-independent toxicity. The results of the screen are
detailed in Additional file 1: Table S1 and summarized in
Figures 1 and 2 and Table 1.We defined hits as crosses in which knockdown resulted
in statistically significant sucrose-sensitive toxicity at a
0.05 threshold. We defined strong hits as results that




































































































































































































































































































Figure 1 Effect of sucrose on survival of RNAi candidates. Ranked estimates and confidence intervals (orange/purple: 95%, gray:
Bonferroni-adjusted, N = 113) for the ln(OR) of knockdown vs. non-knockdown sibling pupariation on 1.0 M sucrose vs. 0.15 M sucrose. For each
human gene, the cross with the most dramatic effect is shown; crosses that were lethal independent of dietary sucrose are omitted. Bars are
labeled with the names of the human orthologs corresponding to each RNAi line; the names of the RNAi lines themselves are in Additional file 1:
Table S1. We considered crosses whose 95% confidence intervals exclude zero as hits, and we considered crosses whose Bonferroni-adjusted
confidence intervals exclude zero as strong hits. In a few cases, a gene was a hit in both directions; in such cases, both crosses are shown and
the gene name is marked with an asterisk. More complete details are in Additional file 1: Tables S1 and S2.
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sucrose tolerance could be assessed (we excluded crosses
where sucrose tolerance could not be assessed due to
sucrose-independent lethality). 47 of the screened lines
were hits, corresponding to 34 human genes; 29 of these
were strong hits, corresponding to 22 human genes. As a
control, we verified that the relative survival to
pupariation was similar for flies fed 1.0 M sucrose vs.
0.15 M sucrose food for the GD and KK genetic
backgrounds (without RNAi transgenes) used in the study
(Additional file 1: Table S2, Figure 1).
Regions containing a single candidate gene
The approximately 100 kb radius window we applied
included only a single human gene at 12 regions. At each
of these regions, it seems plausible that variants in this
single gene are causative for the associated traits. 10 of
these regions were tested with fly orthologs (two regions
did not contain fly orthologs). Seven fly orthologs were
identified as hits in at least one cross. Strong hits
corresponded to PPARG and TCF7L2 (T2D candidates),
LIPC (HDL candidate), and LPL (TG and HDL candidate);
orthologs of ADAMTS9 and SLC30A8 (T2D candidates)
and TRIB1 (TG candidate) were also hits. The 7/10 hit
rate at single-gene regions indicates that our model likely
reflects at least some important aspects of human T2D
and related QTs, and that our assay can provide useful
modifier data.
Not all single-gene regions tested positive in our
Drosophila assay: orthologs of GALNT2, CDKAL1, and
JAZF1 failed to display modifier activity (Figures 1 and
2, Table 1, Additional file 1: Table S1). This may be due
to several factors. First, the RNAi constructs and
insertions used work with differing efficacy, at least in
part likely due to their random insertion sites within
the genome [24]. Consistent with this phenomenon,
some RNAi lines targeting the same Drosophila gene
gave discordant results in our assay; most commonly,
one line showed modifier activity and another did not.Second, phylogenetic inference of orthology may not
be correct. Indeed, Ensembl’s inferences were refined
while our study was underway. Third, the GWAS result
may be a false positive, or the true causative variant
may lie outside of the window we initially selected or
may be undetected within the region. However,
GALNT2 acts in metabolic pathways [25] and a coding
mutation in CDKAL1 has been closely correlated with
T2D risk in humans [26]. Fourth, our screening ap-
proach may not identify loci that are risk factors due to
upregulation. Lastly, failure of Drosophila to confirm
modifier status for several of these regions may reflect
limitations of using flies to explore GWAS.
Regions containing multiple candidate genes
At the remaining regions, our approximately 100 kb
radius window defined more than one candidate human
gene, many with fly orthologs. The region near rs4607517
contains the gene GCK, encoding glucokinase, which is
required for glucose-stimulated insulin secretion and
proper glucose metabolism. GCK mutations are causa-
tive alleles in a monogenic form of diabetes [27], making
it a strong candidate to further validate our approach.
Indeed, sucrose-specific toxicity was strongly enhanced
by knockdown of all but one of the four putative fly
orthologs of GCK (Figure 1, Additional file 1: Table S1).
For other regions we tested orthologs of multiple
human genes, and at six of the remaining regions our
sucrose toxicity screen implicated a single human gene
ortholog. These genes were THADA and IGF2BP2 (T2D
candidates), CELSR2 (LDL candidate), NRBP1 (TG candi-
date), SLC12A3 and LIPG (HDL candidates). At six
regions our screen did not identify any hits. While this
may be explained in part by potential lack of sensitivity in
our system, in all cases these regions included other genes
we were not able to test.
At nine regions, our screen implicated more than one
human gene. This may reflect a lack of specificity of this





























































































































































































































20 21 22 X Y
 strong hit 
 hit 
 not hit 
 lethal 
 not tested 
 no RNAi available 
 no ortholog 
Figure 2 Graphical summary of the Drosophila sucrose-intolerance screen. The 38 regions of interest, and the human genes located in
them, are marked on a schematic karyogram of the human genome. The regions are labeled with the metabolic traits with which they are
associated. The gene names are color-coded to indicate their outcome in our screen. More complete details are in Additional file 1: Table S1.
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ology. On the other hand, these results highlight the fact
that model organism screening has the ability to identify
multiple modifier loci within a single region and at the
level of individual genes. Of particular utility, genes that
are tightly linked in humans can be subjected to individual
functional testing using specific RNAi knockdown. A
striking example of this is a region at 10q23.33 that
contains IDE, KIF11, and HHEX, three genes with clear
one-to-one fly orthologs. Genome-wide scans [12,13,28]
have consistently reported SNP signals associated with
T2D near this region. Attention has focused on HHEX,
which has been most closely linked with these signals [29],
and which encodes a metabolism-related HOX-class
transcription factor. Indeed, our screening identified
CG7056—which we refer to here as dHHEX—as the
most robust modifier of sucrose-mediated lethality in
our study (Figure 1, Additional file 1: Table S1).
We also identified Drosophila orthologs of the
neighboring genes IDE and KIF11—Drosophila genes ide
and klp61F—as modifiers (Figures 1 and 2, Additional file
1: Table S1). Intriguingly, IDE knockout mice exhibit hy-
perglycemia and insulin insensitivity in an age-dependent
manner [30,31]. KIF11 has also been knocked out in mice
but is embryonic lethal; metabolic effects of partial loss of
KIF11 have not been characterized [32]. Our data suggest
that IDE and KIF11 may contribute to patients’ metabolic
risk. Their role may be obscured by the high risk con-
ferred by neighboring HHEX locus; the three loci may act
independently, or perhaps variations in copy number
affect the three loci to increase patient risk.
Further characterization of dHHEX: diet
We next used Drosophila to further explore aspects of
dHHEX’s role in the response to high dietary sucrose.
Raised on a variety of feeding conditions (Additional file 1:
Table S3, Figure 3A) tubP>RNAi
dHHEX flies remained
comparable to wild type on a number of stressful diets
including diets containing hydrogen peroxide and silver
nitrate and, notably, a high-fat diet. We observed elevated
lethality when tubP>RNAi
dHHEX flies were raised on high-
salt diets (slightly hyperosmolar relative to 1.0 M sucrose
food). This result suggests an impaired ability to respond
to hyperosmolar conditions that may contribute to
sucrose-dependent lethality. To better understand the role
of dHHEX specifically in glucose metabolism, we used
dietary glucosamine to explore the hexosamine biosyn-
thetic pathway (HBP), a primary pathway of glucose me-
tabolism. The HBP has been implicated in mechanisms of
glucose toxicity [33] and dietary glucosamine increases
HBP flux in flies [34]. tubP>RNAi
dHHEX flies proved
glucosamine-intolerant: the addition of 0.1 M glucosamine
to a control diet resulted in failure to pupariate. The abil-
ity of low levels of glucosamine to cause lethality suggeststhat glucose metabolism is indeed a primary effector of
dietary sucrose toxicity in tubP>RNAi
dHHEX flies.
Further characterization of dHHEX: tissues
We next used targeted knockdown to determine which
tissues require normal dHHEX activity in the face of
high dietary sucrose (Additional file 1: Table S4,
Figure 3B–C). Mammalian studies have implicated
HHEX function in diverse tissues and organs including
liver, heart, pancreas, thyroid, and hematopoietic cells
[35-39]. We used a panel of tissue-selective GAL4 lines
to direct expression of the UAS-RNAidHHEX transgene
in specific tissues: dilp2-GAL4 targets insulin producing
cells (beta cell analogs), Cg-GAL4 targets several tissues
including the fat body (functional analog of mammalian
liver and adipose tissue), Dot-GAL4 targets several
tissues including nephrocytes (functional analogs of
glomerular podocytes) and gut, GMH5 targets heart, srp.
Hemo-GAL4 targets hemocytes (phagocytic blood cell
analogs) as well as nephrocytes, snsGCN-GAL4 targets
nephrocytes, esg-GAL4 targets several cell types including
midgut stem cells, MyoIA-GAL4 targets differentiated
midgut, and byn-GAL4 targets hindgut. Flies carrying a
GAL4 driver plus UAS-RNAidHHEX were raised on high-
sucrose diets along with control animals, and the number
of knockdown to non-knockdown animals surviving to
pupariation or eclosion on high or low sucrose was
scored. Of the three distinct UAS-RNAidHHEX lines we
used in the initial screen, we focused on the V15721 line,
which exhibited the most survival of knockdown flies on
0.15 M sucrose when driven by tubP-GAL4.
Knockdown of dHHEX in the heart, hemocytes,
nephrocytes, hindgut, and differentiated midgut did not
affect viability on high-sucrose feeding compared to low-
sucrose feeding, and perhaps surprisingly, neither did
knockdown in the insulin producing cells or the fat body
(Figure 3B–C). However, knockdown driven by either
Dot-GAL4 or esg-GAL4 did affect survival to eclosion in a
sugar-sensitive manner (although, interestingly, knockdown
driven by Dot-GAL4 did not affect survival to pupariation).
Both of these drivers express in a range of tissues but one
point of overlap in their domains is in the midgut stem
cells.
Further characterization of dHHEX: metabolics
Given the fat body’s important role in metabolism, we
profiled hemolymph (blood) glucose, body size, and
whole-animal triglyceride levels in Cg>RNAidHHEX-V15721
wandering third-instar and adult flies reared on 1.0 M su-
crose. Dicer-2 (Dcr-2) overexpression was included to en-
hance RNAi efficacy [24]. Female flies were studied
because this experimental genotype is male-lethal.
Both larval and adult Cg>RNAidHHEX-V15721, Dcr-2 flies













































































































































































































































Figure 3 Diet-specific and tissue-specific lethality of dHHEX knockdown. A. tubP>RNAi
dHHEX-V15721 flies tolerate many non-ideal diets, but are
sensitive to high sucrose, as well as to glucosamine and to high salt. Estimates and confidence intervals (green: 95%, gray: Bonferroni-adjusted,
N = 12) of ln(OR) are shown comparing odds of knockdown vs. non-knockdown animals pupariating compared to the genetic background
control on that diet. More complete details are in Additional file 1: Table S3. B–C. tubP-GAL4, Dot-GAL4, and esg-GAL4 driving dHHEX knockdown
using UAS-RNAidHHEX-V15721 confer lethality on high sucrose, but a number of other drivers do not. Estimates and confidence intervals (colored:
95%, gray: Bonferroni-adjusted, N = 11) of ln(OR) are shown for survival of knockdown vs. non-knockdown animals, compared to the genetic
background control. Pupariation (unmarked) or eclosion (asterisks) or both were scored. More complete details are in Additional file 1:
Tables S4 and S5.
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Additional file 1: Table S6, Figure 4B–C). Since flies have
a single receptor that is orthologous to both human in-
sulin and human IGF1 receptors, and since this receptor
controls both glucose homeostasis and growth [40-42],
the smaller body size of knockdown animals suggests
that Cg>RNAidHHEX-V15721, Dcr-2 flies have decreased
insulin signaling activity and hence increased insulin
resistance when confronted with high dietary sucrose.
Consistent with this view, wandering (non-feeding)
Cg>RNAidHHEX-V15721, Dcr-2 larvae were hyperglycemic
after high-dietary-sucrose rearing (p < 0.029, Additional
file 1: Table S6, Figure 4A). Intriguingly, in both
Cg>RNAidHHEX-V15721, Dcr-2 larvae and adults, hypergly-
cemia and reduced body size were accompanied by signifi-
cantly lower triglyceride levels when compared to controls
(p < 0.007, Additional file 1: Table S6, Figure 4D–E).Conclusions
To date, genome-wide scans for genes and alleles that
contribute to metabolic disease risk have identified
numerous candidates, but functional follow-up studies
have been more difficult to perform in mammalian
systems. We hypothesized that human genes involved in
susceptibility to developing T2D and related traits can
be prioritized by knocking down their fly orthologs and
assaying sucrose-sensitive lethality. Evidence in support
of our hypothesis includes the fact that this assay identi-
fies GCK, a gene known to cause a monogenic form of
diabetes, and the fact that sucrose-sensitive lethality
correlates with metabolic abnormalities in the flies. To
our knowledge, this is the first large-scale functional
study of metabolic-trait candidate genes identified by
GWAS analysis, and the first to specifically address an
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Figure 4 Metabolic profiling of Cg>RNAidHHEX-V15721, Dcr-2. A. Wandering third-instar females of Cg>RNAidHHEX-V15721, Dcr-2 are hyperglycemic.
Each measurement is made from a pooled sample of hemolymph from 5–8 animals; dark red line segments show mean values. p < 0.029. B–C.
Wandering third-instar and newly eclosed adult females of Cg>RNAidHHEX-V15721, Dcr-2 have reduced body size. Each measurement is the mean
per-animal mass of a group of 6–10 animals; dark red line segments show mean values. p < 0.001 for both larvae and adults. D–E. Wandering
third-instar and newly eclosed adult females of Cg>RNAidHHEX-V15721, Dcr-2 have reduced triglyceride levels. Each measurement is made from a
pooled sample of whole-animal homogenate from 6–10 animals; dark red line segments show mean values. p < 0.007 for both larvae and adults
(p < 0.002 for adults when one extreme outlier is excluded). All p-values for metabolic data were calculated using a bidirectional t-test without
assuming equal variances. More complete details are in Additional file 1: Tables S6–S8.
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Drosophila HHEX ortholog, we have shown that this
gene plays an important role in whole-animal metabol-
ism in this system through its effects in the fat body—a
functional analog of mammalian liver and adipose tissue.
Loss of dHHEX results in insulin resistance and hyper-
glycemia and, interestingly, a reduction of whole-animal
triglyceride levels in this system. It has been proposed
that the conversion of fatty acids into triglycerides
may protect against tissue lipotoxicity [43]; the hyper-
glycemia observed in Cg>RNAidHHEX-V15721, Dcr-2 flies
suggests dHHEX may play a role in determining the
capacity of the fly to store energy as triglycerides. We
additionally showed that there are multiple other
candidate genes for T2D and related QTs (fasting
glucose, triglycerides, LDL, and HDL) that have diet-
dependent roles in overall organismal viability. Fur-
ther systematic study of these genes, including T2D
candidate genes such as PPARG, IDE, and KIF11, may
help elucidate their molecular functions in their respective
pathways. Since many fundamental aspects of metabolismhave been conserved during evolution, it is reasonable to
hypothesize that these functions may be similar in humans
as in flies; whether this is true will, of course, have to be
determined case by case.
In general, Drosophila offers a rich resource for provid-
ing rapid, inexpensive, whole-animal tests of gene func-
tion. In addition to screening candidate genes identified
by GWAS approaches, this same approach could prove
useful, as whole genome sequencing becomes more com-
mon, for identifying specific mutations that are causative
rather than simply correlated. Perhaps its most important
advantage is the ability to assess all candidates in an




RNAi stocks (listed in Additional file 1: Table S1) were
acquired from the Vienna Drosophila Resource Center,
as well as genetic background controls w1118 (for GD
lines, VDRC #60000) and y– w1118; P{attP, y+, w3’}VIE-
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http://www.biomedcentral.com/1471-2164/14/136260B (for KK lines, VDRC #60100) [24]. tubP-GAL4
(BDSC #5138) [44], Cg-GAL4 (BDSC #7011) [45],
dilp2-GAL4 (BDSC #37516) [46], esg-GAL4 (BDSC
#26816), Dot-GAL4 (BDSC #6903) [47,48], UAS-Dcr-2
(BDSC #24648) [24], and TM6B,Tb1 (BDSC #120) are
available from the Bloomington Drosophila Stock
Center. MyoIA-GAL4 (DGRC-K #112001) is available
from the Drosophila Genetic Resource Center, Kyoto.
Additional fly stocks were generously provided by the
Drosophila community: GMH5 by Rolf Bodmer [49],
snsGCN-GAL4 by Susan Abmayr [50], srp.Hemo-GAL4
by Katja Brückner [51,52], byn-GAL4 by Volker
Hartenstein [53,54], and a T(2;3) balancer by Larry
Zipursky.
Fly media
We modified a commonly used Drosophila semi-defined
medium [55] as previously described [10]. Briefly, we
replaced all added sugars in the recipe (glucose and
sucrose) with 51.3 g/L sucrose (to yield 0.15 M sucrose)
plus any other desired components. The primary screen
was carried out on 0.15 M sucrose (low sucrose) and
1.0 M sucrose (high sucrose) foods.
Scoring and statistics
In tubP-GAL4, byn-GAL4, and snsGCN-GAL4 studies, flies
carrying a GAL4-encoding transgene and a balancer as
the homologous chromosome were crossed to flies
carrying a RNAi-encoding transgene, and survival to
pupariation was scored by counting non-tubby
(driver>RNAi) and tubby (UAS-RNAi; TM6B or a T(2;3)
balancer) pupae, except for a small number of exceptions,
where survival to adulthood of non-curly (tubP>RNAi)
compared to curly (tubP-GAL4; CyO) or non-stubble
(tubP>RNAi) compared to stubble (tubP-GAL4; TM3, Sb
–)
animals was scored instead. In studies of other drivers,
either a similar cross was performed and survival to adult-
hood was scored by counting non-curly (driver>RNAi)
and curly (driver; CyO) animals, or else rates of eclosion
were compared for a fixed number of knockdown
embryos compared to a fixed number of control embryos
possessing the GAL4 insertion and the proper genetic
background, but lacking the RNAi-encoding insertion.
Counts that were extremely different from experimental
replicates were excluded from analysis (3 out of over 800
replicates were excluded in this way). If fewer than 5
knockdown animals survived in all experimental replicates
for a given comparison, then we considered the knockdown
to be generally toxic and did not assess sucrose intolerance.
For each comparison, we used Fisher’s exact test to
assess whether our data were consistent with the null
hypothesis that relative survival of knockdown flies was
the same on high- and low-sucrose feeding, as well as to
compute point estimates and confidence intervals forthe natural logarithm of the odds ratio (ln(OR)) for sur-
vival of the knockdown and control genotypes on high
and low sucrose. We considered crosses to be hits when
statistically significant with a 0.05 threshold, and we
considered crosses to be strong hits when statistically
significant with a Bonferroni-adjusted threshold. For the
RNAi screen for sucrose sensitivity, this threshold
was 4.42 × 10–4, corresponding to 113 crosses tested
(excluding crosses that were lethal on both diets, since
no determination about sucrose sensitivity can be made
for these crosses). For the diet survey, this threshold
was 4.17 × 10–3, corresponding to 12 diets tested. For
the driver survey, this threshold was 4.55 × 10–3, cor-
responding to 11 driver-phenotype pairs tested. We
used confidence intervals for hypothesis testing; they
could in principle also be used for effect-size compari-
son and equivalence testing.
Metabolic parameters were comparing using two-sided
unpaired t-tests without assuming equal variances.
Computations were performed in R, a language and
environment for statistical computing, version 2.15.1.
Plots were generated in R, some using the ggplot2 pack-
age. Some tables were constructed using XeLaTeX and
the longtable and booktabs packages.
Metabolic studies
Hemolymph glucose and whole-animal triglycerides
were measured as previously described [10]. Briefly, to
collect hemolymph, wandering third-instar larvae were
lanced and hemolymph from 5–8 larvae was pooled to
collect 1 μL. Glucose levels were measured using the
Infinity Glucose Hexokinase Reagent kit (Thermo Fisher
#TR15421). Triglycerides were measured using the Infinity
Triglycerides Reagent kit (Thermo Fisher #TR22321) on
whole-animal homogenates of groups of 6–10 animals.
Per-animal mass was measured by weighing groups of
6–10 animals.
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